QSS
NDRM

Quantitative Systematic Strategies’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Quantitative Systematic Strategies’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,124
Closed -$307K – 1017
2015
Q4 		$307K Sell
18,124
-2,440
-12% -$47.5K 0.08% 444
2015
Q3 		$425K Buy
+20,564
New +$422K 0.21% 179

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Quantitative Systematic Strategies's NDRM Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q1 2016, closing a stake of 18,124 shares — an estimated $307K sold.

Quantitative Systematic Strategies first reported a position in NDRM in Q3 2015 and held it in 2 quarters. The position peaked at $425K in Q3 2015. 50 funds tracked by Wall St. Rank hold NDRM as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 18,124 NeuroDerm Ltd. Ordinary Shares shares in Q1 2016, an estimated $307K.
  • Quantitative Systematic Strategies first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's NeuroDerm Ltd. Ordinary Shares position peaked at $425K in Q3 2015.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.